Optimal Immunohistochemical Panel for Distinguishing Esophageal Adenocarcinoma from Squamous Cell Carcinoma

被引：0
|
作者：
DiMaio, M. A. [1 ]
Kwok, S. [1 ]
Montgomery, K. D. [1 ]
Lowe, A. W. [1 ]
Pai, R. K. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
655
引用
收藏
页码：158A / 158A
页数：1
相关论文
共 50 条
  • [31] Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019
    Liu, Kyle S. S.
    Raza, Syed Ahsan
    El-Serag, Hashem B.
    Thrift, Aaron P.
    [J]. CANCERS, 2022, 14 (24)
  • [32] Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
    Terry, Jefferson
    Leung, Samuel
    Laskin, Janessa
    Leslie, Kevin O.
    Gown, Allen M.
    Ionescu, Diana N.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (12) : 1805 - 1811
  • [33] Should adenosquamous esophageal carcinoma be treated like adenocarcinoma or squamous cell carcinoma?
    Gamboa, Adriana C.
    Meyer, Benjamin I.
    Switchenko, Jeffrey M.
    Rupji, Manali
    Lee, Rachel M.
    Turgeon, Michael K.
    Russell, Maria C.
    Cardona, Kenneth
    Kooby, David A.
    Maithel, Shishir K.
    Shah, Mihir M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [34] Classification of Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, and Stomach Adenocarcinoma Based on Machine Learning Algorithms
    Chen, Xiaoping
    Zheng, Lihui
    Yao, Jianqi
    Yang, Cheng-Fu
    [J]. SENSORS AND MATERIALS, 2021, 33 (08) : 2639 - 2654
  • [35] Should Adenosquamous Esophageal Carcinoma be Treated Like Adenocarcinoma or Squamous Cell Carcinoma?
    Gamboa, A. C.
    Meyer, B. I.
    Switchenko, J. M.
    Rupji, M.
    Lee, R. M.
    Turgeon, M.
    Russell, M. C.
    Cardona, K.
    Kooby, D. A.
    Maithel, S. K.
    Shah, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S202 - S203
  • [36] Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma
    Mega, S.
    Miyamoto, M.
    Li, L.
    Kadoya, M.
    Takahashi, R.
    Hase, R.
    Kaneko, H.
    Shichinohe, T.
    Kawarada, Y.
    Itoh, T.
    Morikawa, T.
    Kondo, S.
    [J]. DISEASES OF THE ESOPHAGUS, 2006, 19 (05) : 355 - 359
  • [37] Immunohistochemical prognostic markers of esophageal squamous cell carcinoma:a systematic review
    Chunni Wang
    Jingnan Wang
    Zhaoli Chen
    Yibo Gao
    Jie He
    [J]. 癌症, 2017, 36 (11) : 592 - 608
  • [38] Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis
    Boone, J.
    van Hillegersberg, R.
    Offerhaus, G. J. A.
    van Diest, P. J.
    Rinkes, I. H. M. Borel
    ten Kate, F. J. W.
    [J]. DISEASES OF THE ESOPHAGUS, 2009, 22 (06) : 496 - 504
  • [39] Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review
    Wang, Chunni
    Wang, Jingnan
    Chen, Zhaoli
    Gao, Yibo
    He, Jie
    [J]. CHINESE JOURNAL OF CANCER, 2017, 36
  • [40] Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
    Xiao, Jian
    Lu, Xiaoxiao
    Chen, Xi
    Zou, Yong
    Liu, Aibin
    Li, Wei
    He, Bixiu
    He, Shuya
    Chen, Qiong
    [J]. ONCOTARGET, 2017, 8 (42) : 71759 - 71771
12345